ProQR Therapeutics N.V. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Leiden
SEC filing record 1 source field available
Fiscal year end
31 December
ProQR Therapeutics N.V. has filed 387 SEC EDGAR filings since 11 Jul 2014

SEC filing history

Showing 101-125 of 387 matching filings.

Per page
25
Current page
5
6-K File 001-36622

FORM 6-K

Filing date
27 Sep 2023
Reporting date
27 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88671

SC 13G

Filing date
14 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
01 Aug 2023
Reporting date
01 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
17 May 2023
Reporting date
17 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-270943

EFFECT filing

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-270943

424B5

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
18 Apr 2023
Reporting date
18 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-260780

RW

Filing date
29 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3 File 333-270943

FORM F-3

Filing date
29 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
29 Mar 2023
Reporting date
29 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
10 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

PROQR THERAPEUTICS N.V.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

SC 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

PROQR THERAPEUTICS N.V.

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

SC 13G/A filing

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88671

SC 13G/A

Filing date
23 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
23 Dec 2022
Reporting date
23 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36622

FORM 6-K

Filing date
21 Sep 2022
Reporting date
21 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .